Nektar Therapeutics · San Francisco, CA United States (NASDAQ: NKTR)
| 455 Mission Bay Blvd. South | Phone: 415-482-5300 |
| San Francisco, CA | Fax: 415-339-5300 |
| 94158 | |
| United States | 
Map This Company |
Nektar Therapeutics Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Nektar Therapeutics has pegged its fortunes to making drugs more effective. The clinical-stage drug development firm uses its PEGylation technology, (based upon polyethylene glycol) to improve the delivery and efficacy of existing drugs. Nektar's pipeline is focused on anti-infectives and anti-virals, immunology, oncology, and pain treatments. Its lead candidate NKTR-118 (which it is developing in collaboration with
Nektar Therapeutics Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: NKTR Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 408 |
Executives
25 executives listed for Nektar Therapeutics's San Francisco, CA location.
| Chairman | Robert Chess | |
|---|---|---|
| President, CEO, and Director | Howard Robin | |
| SVP Finance and CFO | John Nicholson |